InsidersTradesSigma
Discover the complete record of transactions filed by Hunder Naomi, Directeur Médical. Insider active across 1 companies, notably Silverback Therapeutics, Inc.. Aggregated, 3 disclosures have been published. The latest transaction was filed on 2 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Hunder Naomi serves as Chief Medical Officer for Silverback Therapeutics, Inc. In this role, she oversees the company's medical initiatives and research programs. Her expertise in medicine and biotechnology is essential for developing innovative treatments. Hunder is committed to improving patient health through advanced therapeutic solutions.